Andersen Eric's Form 4/A amendment
AmendedMerrimack Pharmaceuticals Inc (MACK) · filed Sep 20, 2021
- Accession no.
- 0000899243-21-036576
- Filed
- Sep 20, 2021, 4:05 PM ET
- Trade date
- Apr 14-Jul 1, 2021
- Filing delay
- 159 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Apr 16, 2021
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $651.9K. Open-market sales total $338.1K. It was filed 159 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Andersen EricCIK 0001517667 | Director, Other: See remarks |
| Western Standard Partners LPCIK 0001450414 | Other: See Remarks |
| Western Standard LLCCIK 0001517666 | Other: See Remarks |
| Western Standard Partners QP, L.P.CIK 0001544857 | Other: See Remarks |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2021 | Common Stock | PPurchaseAcquired | +40,805 | $6.63 | +$270,655.48 | 947,306 | Indirect | |
| Apr 14, 2021 | Common Stock | PPurchaseAcquired | +6,495 | $6.63 | +$43,080.69 | 322,252 | Indirect | |
| Jul 1, 2021 | Common Stock | PPurchaseAcquired | +52,914 | $6.39 | +$338,120.46 | 1,000,220 | Indirect | |
| Jul 1, 2021 | Common Stock | SSaleDisposed | −52,914 | $6.39 | −$338,120.46 | 269,338 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.